++
Chapter 5: Drugs Affecting the Cholinergic System
++
++
++
Inhibition of muscarinic receptors may result in which of the following adverse effects?
++
++
++
++
++
++
++
++
++
++
++
++
Inhibition of which of the following receptors would result in skeletal muscle paralysis?
++
++
++
a. Nicotinic type-N (NN) receptors
++
++
b. Nicotinic type-M (NM) receptors
++
++
c. Muscarinic-1 (M1) receptors
++
++
d. Muscarinic-2 (M2) receptors
++
++
++
Malignant hyperthermia is a potential adverse effect associated with which of the following drugs?
++
++
++
++
++
++
++
++
++
++
++
++
Which of the following drug classes may be clinically used to improve muscle weakness in individuals with myasthenia gravis?
++
++
++
++
++
b. Nicotinic type-N (NN) antagonists
++
++
c. Muscarinic antagonists
++
++
d. Indirect-acting cholinergic agonists
++
++
++
Which of the following drugs has addictive potential?
++
++
++
++
++
++
++
++
++
++
++
++
Which of the following drug classes may decrease hyperactivity of the bladder in a person with a spinal cord injury?
++
++
++
++
++
b. Nicotinic type-N (NN) antagonists
++
++
c. Muscarinic antagonists
++
++
d. Nicotinic type-M (NM) antagonists
++
++
++
Which of the following is an adverse effect associated with muscarinic agonists?
++
++
++
++
++
++
++
++
++
++
++
++
Which of the following drugs has clinical application for motion sickness?
++
++
++
++
++
++...